---

$120.90

+1.3000 ( +1.09% ) 0.5K

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Open	$120.90
Previous Close	$119.60
Volume	0.5K
Market Cap	$5.00B
Day Range	$119.75 - $121.00
52 Week Range	$32.00 - $131.24
Shares Outstanding	41.78M
Change %	+1.09%
Net Change	▲ 1.3000
Insider Ownership	N/A
Exchange	NYSE
Sector
Industry	PHARMACEUTICAL PREPARATIONS
IPO Year	2026
Country	United States
Underwriter	Jefferies, Leerink Partners, Citi, Cantor Fitzgerald, more

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
No records found.